Relaxation of androgens on rat thoracic aorta: testosterone concentration dependent agonist/antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted to L-type Ca2+ channel blockade
| dc.contributor.affiliation | Instituto de Investigaciones Biomédicas, Departamento de Biología Celular y Fisiología, and Facultad de Medicina, Departamento de Farmacología, México D.F. 04510. | es_ES |
| dc.creator | Montaño, L.M. | |
| dc.creator | Calixto, E. | |
| dc.creator | Figueroa, A. | |
| dc.creator | Flores-Soto, E. | |
| dc.creator | Carbajal, V. | |
| dc.creator | Perusquía, M. | |
| dc.creator.identificador | "http://orcid.org/0000-0002-8329-4918">Montaño, Luis M. | es_ES |
| dc.date.accessioned | 2017-06-29T06:02:44Z | |
| dc.date.accessioned | 2026-03-27T14:35:46Z | |
| dc.date.available | 2017-06-29T06:02:44Z | |
| dc.date.issued | 2008 | es_ES |
| dc.date.published | 2008 | es_ES |
| dc.description.abstractotrodioma | Androgen vasorelaxing action is a subject of recent interest. We investigated the involvement of l-type voltage-operated Ca(2+) channels (L-VOCCs), K(+) channels, intracellular Ca(2+) concentration ([Ca(2+)]i), and cAMP in the vasorelaxing effect of testosterone and 5beta-dihydrotestosterone (5beta-DHT) on rat thoracic aorta. Isolated aortic rings were used to study the vasorelaxing potency of testosterone and 5beta-DHT on KCl- and noradrenaline-induced contractions. Patch-clamp was used to analyze androgen effects on Ca(2+) inward and K(+) outward currents. The fluorescence technique was used to evaluate [Ca(2+)]i in single myocytes; moreover, simultaneous measurements of [Ca(2+)]i and vascular contraction were evaluated. 5beta-DHT was more potent than testosterone to relax KCl-induced contraction, but they were equipotent to relax noradrenaline contraction. l-type Ca(2+) currents were blocked by nifedipine, both androgens, and an estrogen in a concentration-dependent manner, and the order of potency was: testosterone > nifedipine > 5beta-DHT > 17beta-estradiol. We observed that testosterone has different mechanism of action by the concentration range used: at nm concentrations it was a powerful L-VOCCs antagonist, whereas at mum concentrations it was observed that: 1) its Ca(2+) antagonist property is reverted by increasing the l-type inward Ca(2+) currents (Ca(2+) agonist property); and 2) the [Ca(2+)]i and cAMP production was increased. The total K(+) currents were unaffected by testosterone or 5beta-DHT. The data show that 5beta-DHT-induced vasorelaxation is due to its selective blockade on L-VOCCs (from nm to microm concentrations), but testosterone-induced vasorelaxation involves concentration-dependent additional mechanisms: acting as an L-VOCCs antagonist at low concentrations, and increasing [Ca(2+)]i and cAMP production at high concentrations. | es_ES |
| dc.description.month | May | es_ES |
| dc.identifier | 557 | es_ES |
| dc.identifier.citation | Alberto Darío Ramírez González | es_ES |
| dc.identifier.doi | 10.1210/en.2007-1288 | es_ES |
| dc.identifier.eissn | 1945-7170 | es_ES |
| dc.identifier.issn | 0013-7227 | es_ES |
| dc.identifier.numero | 5 | es_ES |
| dc.identifier.organizacion | Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz | es_ES |
| dc.identifier.paginacion | 2517-2526 | es_ES |
| dc.identifier.place | United States | es_ES |
| dc.identifier.uri | https://doi.org/10.1210/en.2007-1288 | es_ES |
| dc.identifier.uri | https://repositorio.inprf.gob.mx/handle/123456789/5244 | |
| dc.identifier.volumen | 149 | es_ES |
| dc.language.iso | eng | es_ES |
| dc.relation | 149 (5) 2517-2526 p. | es_ES |
| dc.relation | versión del editor | es_ES |
| dc.relation.jnabreviado | ENDOCRINOLOGY | es_ES |
| dc.relation.journal | Endocrinology | es_ES |
| dc.rights | acceso cerrado | es_ES |
| dc.subject.mesh | Androgens-pharmacology | es_ES |
| dc.subject.mesh | Animals | es_ES |
| dc.subject.mesh | Aorta, Thoracic-drug effects | es_ES |
| dc.subject.mesh | Aorta, Thoracic-physiology | es_ES |
| dc.subject.mesh | Calcium-metabolism | es_ES |
| dc.subject.mesh | Calcium Channel Agonists-pharmacology | es_ES |
| dc.subject.mesh | Calcium Channel Blockers-pharmacology | es_ES |
| dc.subject.mesh | Calcium Channels, L-Type-metabolism | es_ES |
| dc.subject.mesh | Cells, Cultured | es_ES |
| dc.subject.mesh | Dihydrotestosterone-pharmacology | es_ES |
| dc.subject.mesh | Dose-Response Relationship, Drug | es_ES |
| dc.subject.mesh | Male | es_ES |
| dc.subject.mesh | Membrane Potentials-drug effects | es_ES |
| dc.subject.mesh | Muscle Cells | es_ES |
| dc.subject.mesh | Osmolar Concentration | es_ES |
| dc.subject.mesh | Potassium-metabolism | es_ES |
| dc.subject.mesh | Rats | es_ES |
| dc.subject.mesh | Rats, Wistar | es_ES |
| dc.subject.mesh | Substrate Specificity | es_ES |
| dc.subject.mesh | Testosterone-pharmacology | es_ES |
| dc.subject.mesh | Vasodilation-drug effects | es_ES |
| dc.title | Relaxation of androgens on rat thoracic aorta: testosterone concentration dependent agonist/antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted to L-type Ca2+ channel blockade | es_ES |
| dc.type | article | es_ES |
